Inhibition of GFAT in IFNγ-treated cancer cells was found to inhibit PD-L1 glycosylation, accelerating its proteasomal degradation and, more importantly, enhancing T cell activation and anti-cancer activity of natural killer cells (62). Here, IFNG is linked to cancer.